Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Is angiotensin I-converting enzyme a "master" disease gene?

Diabetes technology & therapeutics - 1 Jan 2002

Moskowitz David W

Abstract excerpt

Clustering of diseases has been appreciated by health insurers and epidemiologists for some time. Co-morbidity suggests shared pathways of disease. It is by now well agreed that common diseases have a strong genetic component. Here we present evidence that the angiotensin I-converting enzyme (ACE) deletion/deletion (D/D) genotype is associated with a large number of common adult diseases, including cardiovascular...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Black or African American
Share to Black People
Share to France

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genetic Diseases, Inborn

Share to Odds Ratio

Share to Peptidyl-Dipeptidase A

Share to Sex Characteristics

Share to United States

Source

Identifiers

PMID: 12458570
DOI: 10.1089/152091502320798321

Genes

ACE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Is angiotensin I-converting enzyme a "master" disease gene?PMID 12458570Read ↗

Angiotensin-converting-enzyme insertion/deletion polymorphism, ACE activity, and COVID-19: A rather controversial hypothesis. A case-control study.Semantic proximity Read ↗

Ethnic Prevalence of Angiotensin-Converting Enzyme Deletion (D) Polymorphism and COVID-19 Risk: Rationale for Use of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers.Semantic proximity Read ↗

Association between angiotensin-converting enzyme insertion/deletion polymorphisms and the risk of heart disease: an updated meta-analysis.Semantic proximity Read ↗

ACE phenotyping as a first step toward personalized medicine for ACE inhibitors. Why does ACE genotyping not predict the therapeutic efficacy of ACE inhibition?Semantic proximity Read ↗

From pharmacogenomics to improved patient outcomes: angiotensin I-converting enzyme as an example.Semantic proximity Read ↗

Genetics of angiotensin I-converting enzyme.Semantic proximity Read ↗

From an ACE polymorphism to genome-wide searches for eQTL.Semantic proximity Read ↗

[ACE gene polymorphism and cardiovascular diseases].Semantic proximity Read ↗

Angiotensin I-converting enzyme: genotype and disease associations.Semantic proximity Read ↗

Angiotensin-converting enzyme gene deletion allele increases the risk of left ventricular hypertrophy: evidence from a meta-analysis.Semantic proximity Read ↗

The effect of angiotensin-converting enzyme insertion/deletion polymorphism on severity and death rate of COVID-19 in Iranian patientsSemantic proximity Read ↗

Angiotensin-converting enzyme deletion allele is beneficial for the longevity of Europeans.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.